Literature DB >> 21172874

The role of osteoclast-associated receptor in osteoimmunology.

Katharina Nemeth1, Michael Schoppet, Nadia Al-Fakhri, Susann Helas, Rolf Jessberger, Lorenz C Hofbauer, Claudia Goettsch.   

Abstract

The term osteoimmunology is coined for molecular and cellular cross talk between the skeletal and immune system. Immunomodulatory signals have long been implicated as key regulators of bone metabolism. Recently, osteoclast-associated receptor (OSCAR), an IgG-like receptor, has been identified as an important osteoimmunological mediator. OSCAR expression in bone is highly conserved across different species, and the molecule is an important costimulatory receptor for osteoclast differentiation through activation of NFATc1. In humans, OSCAR is expressed by macrophages, monocytes, and monocyte-derived dendritic cells and modulates the response of the innate and adaptive immune systems by promoting cell activation and maturation, Ag presentation, and proinflammatory circuits. Human studies indicate that OSCAR may contribute to the pathogenesis and severity of osteoporosis and rheumatoid arthritis. In this paper, we review the structure-function relationship, expression pattern, and physiological role of OSCAR in osteoimmunology and summarize its potential implications for human diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21172874     DOI: 10.4049/jimmunol.1002483

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Collagen binding to OSCAR: the odd couple.

Authors:  Bo An; Barbara Brodsky
Journal:  Blood       Date:  2016-02-04       Impact factor: 22.113

2.  Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein α (SIRPα) signaling.

Authors:  Cecilia Koskinen; Emelie Persson; Paul Baldock; Åsa Stenberg; Ingrid Boström; Takashi Matozaki; Per-Arne Oldenborg; Pernilla Lundberg
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

Review 3.  Notch and the regulation of osteoclast differentiation and function.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  Bone       Date:  2020-06-08       Impact factor: 4.398

4.  Osteoclast activators are elevated in intervertebral disks with Modic changes among patients operated for herniated nucleus pulposus.

Authors:  Matias Torkki; Marja-Leena Majuri; Henrik Wolff; Tatu Koskelainen; Marianne Haapea; Jaakko Niinimäki; Harri Alenius; Jeffrey Lotz; Jaro Karppinen
Journal:  Eur Spine J       Date:  2015-03-27       Impact factor: 3.134

Review 5.  New understanding and treatments for osteoporosis.

Authors:  G Mazziotti; J Bilezikian; E Canalis; D Cocchi; A Giustina
Journal:  Endocrine       Date:  2012-02       Impact factor: 3.633

Review 6.  Updating osteoimmunology: regulation of bone cells by innate and adaptive immunity.

Authors:  Matthew C Walsh; Noriko Takegahara; Hyunsoo Kim; Yongwon Choi
Journal:  Nat Rev Rheumatol       Date:  2018-01-11       Impact factor: 20.543

7.  Osteoclasts are not activated in middle ear cholesteatoma.

Authors:  Hiroki Koizumi; Hideaki Suzuki; Shoji Ikezaki; Toyoaki Ohbuchi; Koichi Hashida; Akinori Sakai
Journal:  J Bone Miner Metab       Date:  2015-03-22       Impact factor: 2.626

8.  The role of RANK ligand/osteoprotegerin in rheumatoid arthritis.

Authors:  Piet Geusens
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-08       Impact factor: 5.346

9.  Correlations of soluble osteoclast-associated receptor (sOSCAR) with acute coronary syndrome.

Authors:  Qing Zhang; Wei Qiao; Lei Zhou; Hui Jin; Kou-Long Zheng; Dong-Sheng Zhao; Hui-He Lu
Journal:  Ann Transl Med       Date:  2018-10

Review 10.  Serine/threonine phosphatases in osteoclastogenesis and bone resorption.

Authors:  Ismael Y Karkache; Jeyaram R Damodaran; David H H Molstad; Elizabeth W Bradley
Journal:  Gene       Date:  2020-12-16       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.